Related Experiment Video
Updated: Jul 17, 2026
07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
Olfaction and neurodegeneration in HD
Fernando A Barrios1, Leopoldo Gonzalez, Rafael Favila
1Institute of Neurobiology, National Autonomous University of Mexico.
Neuroreport
|January 30, 2007
Summary
Olfactory deficits in neurodegenerative diseases like Huntington's disease are linked to specific brain structure degeneration. Key affected areas include the entorhinal cortex, thalamus, parahippocampal gyrus, and caudate nucleus.
Area of Science:
- Neuroscience
- Neurology
- Neurodegeneration
Background:
- Olfactory deficits are common in neurodegenerative diseases.
- The underlying neural mechanisms and disease-specific patterns of olfactory impairment remain unclear.
Purpose of the Study:
- To investigate the relationship between brain structure degeneration and olfactory impairment in Huntington's disease.
- To identify specific brain regions associated with olfactory dysfunction in this neurodegenerative condition.
Main Methods:
- Utilized voxel-based morphometric analysis to assess brain structure changes.
- Correlated structural degeneration with olfactory deficit severity in Huntington's disease patients.
Main Results:
- Significant associations found between olfactory impairment and degeneration in the entorhinal cortex, thalamus, parahippocampal gyrus, and caudate nucleus.
- This study provides the first evidence linking caudate nucleus degeneration to olfactory dysfunction in a neurodegenerative disease.
Conclusions:
- Specific brain structure degeneration, particularly in the entorhinal cortex, thalamus, parahippocampal gyrus, and caudate nucleus, underlies olfactory deficits in Huntington's disease.
- Findings contribute to understanding the neural basis of olfactory dysfunction in neurodegenerative disorders.
Related Concept Videos
01:25Olfaction
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
01:03Olfactory Receptors: Location and Structure
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...